Ben Barres Early Career Acceleration Award (Cycle 2)
Eligibility:
- All applicants must hold a PhD, MD, or equivalent degree and have a faculty position or equivalent independent investigator status at a college, university, medical school or other research facility.
- Applicants should have been in their first independent position for a minimum of two years and less than six years as of the due date for the Letter of Intent application. Independence in an academic setting is typically demonstrated by a full-time faculty appointment, a tenure-track position, allocated space, a start-up package, and institutional commitment as defined or verified in a letter from a department chair or equivalent. Independence may be defined differently in different types of organizations. Note: an upload of the letter or proof of independence is not required at the time of application. CZI will make exceptions to these criteria in cases of institutionally approved career breaks, e.g. family or medical leave, etc. (if this applies to you, please contact sciencegrants@chanzuckerberg.com).
- Applications may be submitted by domestic and foreign non-profit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, units of state and local governments; and eligible agencies of the federal government. For-profit organizations are not eligible. All grants will be awarded to institutions, not individuals.
- There may be more than one application from each institution.
How to Apply:
The Chan Zuckerberg Initiative invites applications for the second cycle of the Ben Barres Early Career Acceleration Awards. This is an investigator award for early career academic investigators, especially those who are new to the field of neurodegeneration. Awards are $1.2M in total costs over 4 years. Early career investigators will benefit from mentored support and resources of the CZI Neurodegeneration Challenge Network.
For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.
External Deadline:
Thursday, April 20, 2023
Agency:
Funding Source:
External
Funding Level:
Research